BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheikh A, Kesharwani P. An insight into aptamer engineered dendrimer for cancer therapy. European Polymer Journal 2021;159:110746. [DOI: 10.1016/j.eurpolymj.2021.110746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Zha S, Li H, Liu H, Wong KL, All AH. Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. Small 2022;:e2203629. [PMID: 36084240 DOI: 10.1002/smll.202203629] [Reference Citation Analysis]
2 Mukherjee S, Mukherjee S, Abourehab MA, Sahebkar A, Kesharwani P. Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy. European Polymer Journal 2022;177:111471. [DOI: 10.1016/j.eurpolymj.2022.111471] [Reference Citation Analysis]
3 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Reference Citation Analysis]
4 Dubey SK, Dey A, Singhvi G, Pandey MM, Singh V, Kesharwani P. Emerging trends of nanotechnology in advanced cosmetics. Colloids Surf B Biointerfaces 2022;214:112440. [PMID: 35344873 DOI: 10.1016/j.colsurfb.2022.112440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Singh A, Ujjwal RR, Naqvi S, Verma RK, Tiwari S, Kesharwani P, Shukla R. Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of alzheimer disease. J Drug Target 2022;:1-52. [PMID: 35382657 DOI: 10.1080/1061186X.2022.2063297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sheikh A, Md S, Alhakamy NA, Kesharwani P. Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121751] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Singh S, Aldawsari HM, Alam A, Alqarni MHS, Ranjan S, Kesharwani P. Synthesis and antimicrobial activity of vancomycin–conjugated zinc coordination polymer nanoparticles against methicillin-resistant staphylococcus aureus. Journal of Drug Delivery Science and Technology 2022;70:103255. [DOI: 10.1016/j.jddst.2022.103255] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY. CD44-Targeted Nanocarrier for Cancer Therapy. Front Pharmacol 2022;12:800481. [DOI: 10.3389/fphar.2021.800481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Singh V, Md S, Alhakamy NA, Kesharwani P. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy. European Polymer Journal 2022;162:110883. [DOI: 10.1016/j.eurpolymj.2021.110883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
11 Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother 2021;146:112530. [PMID: 34915416 DOI: 10.1016/j.biopha.2021.112530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
12 Pooresmaeil M, Namazi H. Developing a new photoluminescent, nanoporous, and biocompatible glycodendrimer for smart hepatic cancer treatment. European Polymer Journal 2021;161:110866. [DOI: 10.1016/j.eurpolymj.2021.110866] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Nitheesh Y, Pradhan R, Hejmady S, Taliyan R, Singhvi G, Alexander A, Kesharwani P, Dubey SK. Surface engineered nanocarriers for the management of breast cancer. Mater Sci Eng C Mater Biol Appl 2021;130:112441. [PMID: 34702526 DOI: 10.1016/j.msec.2021.112441] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]